Perturbation of APP in tumors may represent a strategy to elicit the presentation of both non-mutated tumor antigens with strong antitumor potential, as demonstrated by TEIPPs, and immunogenic epitopes usually destroyed by ERAP1 (53, 55, 57, 68, 69). This evidence concerns the gene APP and neoplasm.